Immix Biopharma, Inc.
IMMX
$2.03
-$0.065-3.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.68M | 19.69M | 23.98M | 29.32M | 17.51M |
| Total Receivables | 1.97M | 1.98M | 1.98M | 2.02M | 1.17M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 509.20K | 1.05M | 1.27M | 1.40M | 1.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.30K | 36.50K | 105.80K | 175.20K | 44.60K |
| Total Current Assets | 20.20M | 22.76M | 27.33M | 32.92M | 19.79M |
|
|
|||||
| Total Current Assets | 20.20M | 22.76M | 27.33M | 32.92M | 19.79M |
| Net Property, Plant & Equipment | 2.73M | 2.37M | 1.48M | 1.41M | 50.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.40K | 20.40K | 20.40K | 20.40K | 87.20K |
| Total Assets | 22.95M | 25.14M | 28.84M | 34.35M | 19.93M |
|
|
|||||
| Total Accounts Payable | 5.39M | 3.29M | 2.35M | 3.51M | 1.43M |
| Total Accrued Expenses | 3.23M | 3.21M | 1.51M | 2.11M | 2.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 65.20K | 62.70K | 48.40K | 34.30K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.69M | 6.56M | 3.90M | 5.66M | 3.72M |
|
|
|||||
| Total Current Liabilities | 8.69M | 6.56M | 3.90M | 5.66M | 3.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.01M | 1.03M | 1.04M | 1.06M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.70M | 7.59M | 4.94M | 6.72M | 3.72M |
|
|
|||||
| Common Stock & APIC | 88.38M | 87.67M | 86.94M | 86.60M | 69.78M |
| Retained Earnings | -75.02M | -70.21M | -63.06M | -58.67M | -53.41M |
| Treasury Stock & Other | -101.00K | 92.10K | 17.00K | -10.30K | 34.70K |
| Total Common Equity | 13.25M | 17.55M | 23.89M | 27.92M | 16.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.25M | 17.55M | 23.89M | 27.92M | 16.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -283.30K | -201.70K |
| Total Equity | 13.25M | 17.55M | 23.89M | 27.63M | 16.20M |
|
|
|||||